Literature DB >> 15868413

Functional expression of mammalian opioid receptors in insect cells and high-throughput screening platforms for receptor ligand mimetics.

L Swevers1, E Morou, N Balatsos, K Iatrou, Z Georgoussi.   

Abstract

Lepidopteran cell lines have been engineered to constitutively express high levels of mouse delta opioid receptors either alone or in combination with human Galpha16 protein. Biochemical and pharmacological studies demonstrate that these lines contain all the mediator G proteins and downstream effectors required for opioid receptor function, including phospholipase C, and that expression of exogenous Galpha16 does not contribute significantly to increased receptor responses upon activation. The activation of the phospholipase C pathway in the transformed cells upon stimulation with known receptor ligands results in easily and quantitatively measurable increases in free intracellular calcium, which can be monitored by automated fluorescent methods, while the addition of specific antagonists blocks the agonist-induced responses. Therefore, the transformed lepidopteran cell lines can be used as sensitive high-throughput screening platforms for fast detection of delta opioid receptor ligand mimetics (agonists and antagonists) in collections of natural products and synthetic compounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868413     DOI: 10.1007/s00018-005-4537-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  2 in total

1.  Inhibition of Anopheles gambiae odorant receptor function by mosquito repellents.

Authors:  Panagiota Tsitoura; Konstantinos Koussis; Kostas Iatrou
Journal:  J Biol Chem       Date:  2015-02-05       Impact factor: 5.157

2.  Expression and membrane topology of Anopheles gambiae odorant receptors in lepidopteran insect cells.

Authors:  Panagiota Tsitoura; Evi Andronopoulou; Daniela Tsikou; Adamantia Agalou; Maria P Papakonstantinou; Georgia A Kotzia; Vassiliki Labropoulou; Luc Swevers; Zafiroula Georgoussi; Kostas Iatrou
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.